136 related articles for article (PubMed ID: 37991858)
41. Scleromyxedema: A rare case report with dermoscopic findings.
Prakashey A; Mehta H; H Bharti A; Agharia R
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):96-98. PubMed ID: 37317775
[No Abstract] [Full Text] [Related]
42. Scleromyxedema in a 21 year old female patient with acute lymphoblastic leukemia: a case report.
Rabee H; Tayem L; Gharbeyah M; Abugaber D
BMC Dermatol; 2020 Dec; 20(1):18. PubMed ID: 33276772
[TBL] [Abstract][Full Text] [Related]
43. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
44. Scleromyxedema.
Heymann WR
J Am Acad Dermatol; 2007 Nov; 57(5):890-1. PubMed ID: 17939940
[No Abstract] [Full Text] [Related]
45. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
[TBL] [Abstract][Full Text] [Related]
46. Papular mucinosis associated with monoclonal gammopathy of unknown significance.
Thatte SS; Dongre AM; Chikhalkar SB; Khopkar US
Indian J Dermatol Venereol Leprol; 2015; 81(2):213-4. PubMed ID: 25751354
[No Abstract] [Full Text] [Related]
47. Widespread skin thickening.
Shimol JB; Vyas N; Evans J
Cutis; 2019 Dec; 104(6):E15-E17. PubMed ID: 31939938
[No Abstract] [Full Text] [Related]
48. Ineffectiveness of infliximab CT-P13 for the treatment of scleromyxedema: A case report.
Arginelli F; Paganelli A; Rongioletti F; Pellacani G; Conti A
Dermatol Ther; 2018 Mar; 31(2):e12583. PubMed ID: 29214719
[No Abstract] [Full Text] [Related]
49. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis.
Knobler R; Moinzadeh P; Hunzelmann N; Kreuter A; Cozzio A; Mouthon L; Cutolo M; Rongioletti F; Denton CP; Rudnicka L; Frasin LA; Smith V; Gabrielli A; Aberer E; Bagot M; Bali G; Bouaziz J; Braae Olesen A; Foeldvari I; Frances C; Jalili A; Just U; Kähäri V; Kárpáti S; Kofoed K; Krasowska D; Olszewska M; Orteu C; Panelius J; Parodi A; Petit A; Quaglino P; Ranki A; Sanchez Schmidt JM; Seneschal J; Skrok A; Sticherling M; Sunderkötter C; Taieb A; Tanew A; Wolf P; Worm M; Wutte NJ; Krieg T
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1581-1594. PubMed ID: 28786499
[TBL] [Abstract][Full Text] [Related]
50. Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.
Lee YH; Sahu J; O'Brien MS; D'Agati VD; Jimenez SA
J Clin Rheumatol; 2011 Sep; 17(6):318-22. PubMed ID: 21869708
[TBL] [Abstract][Full Text] [Related]
51. Scleromyxedema Without Monoclonal Gammopathy Treated with Intravenous Immunoglobulins.
Letzelter M; Grimaux X
Acta Dermatovenerol Croat; 2021 Apr; 291(1):51-53. PubMed ID: 34477065
[TBL] [Abstract][Full Text] [Related]
52. Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema.
Shayegi N; Alakel N; Middeke JM; Schetelig J; Mantovani-Löffler L; Bornhäuser M
Transl Res; 2015 Feb; 165(2):321-4. PubMed ID: 24999269
[TBL] [Abstract][Full Text] [Related]
53. Diffuse skin thickening and linear papules in a 59-year-old woman.
Brelsford M; Mason A; Pariser R
Arch Dermatol; 2012 Nov; 148(11):1317-8. PubMed ID: 23165842
[No Abstract] [Full Text] [Related]
54. Scleromyxedema.
Hoffmann JHO; Enk AH
J Dtsch Dermatol Ges; 2020 Dec; 18(12):1449-1467. PubMed ID: 33373143
[TBL] [Abstract][Full Text] [Related]
55. Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema.
Khandkar C; Vaidya K; Penglase R; Cai K; Shin JS; Hunyor I; Keech A; McGill N
Intern Med J; 2020 Jan; 50(1):127-128. PubMed ID: 31943623
[No Abstract] [Full Text] [Related]
56. [Dermato-neuro syndrome-an acute and life-threatening complication of scleromyxedema Arndt-Gottron].
Linse KP; Enk A; Hoffmann J
Dermatologie (Heidelb); 2023 Aug; 74(8):618-620. PubMed ID: 37284981
[TBL] [Abstract][Full Text] [Related]
57. Atypical scleromyxedema with prominent nodular lesions associated with immune thrombocytopenia: an unusual presentation.
Lopez-Lerma I; Fernandez-Codina A; Hilari H; Ferrer B; Selva-O'Callaghan A; Garcia-Patos V
J Am Acad Dermatol; 2014 Oct; 71(4):e158-9. PubMed ID: 25219747
[No Abstract] [Full Text] [Related]
58. SCLEROMYXEDEMA WITH RETINAL VASCULITIS AND MACULAR EDEMA.
Gutiérrez-Aguirre KI; Stewart MW; Sluzevich JC
Retin Cases Brief Rep; 2017 Fall; 11(4):319-322. PubMed ID: 27348792
[TBL] [Abstract][Full Text] [Related]
59. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes.
Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN
Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389
[No Abstract] [Full Text] [Related]
60. Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins.
Gallo R; Trave I; Cotzia E; Russo R; Parodi A
Acta Derm Venereol; 2022 Dec; 102():adv00836. PubMed ID: 36511333
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
